Stuart McTaggart
Biographic Data
| ID | 6163905 |
|---|---|
| NAME | Stuart McTaggart |
| GIVEN NAMES | Stuart |
| FAMILY NAME | McTaggart |
| SIGNATURE | MCTAGGART S |
| AFFILIATIONS | Public Health and Intelligence Strategic Business Unit, NHS National Services Scotland, Edinburgh, UK |
| ORCID | 0000-0001-6060-9019 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Drug prescriptions and dementia incidence: A medication-wide association study of 17000 dementia cases among half a million participants
BACKGROUND: Previous studies have suggested that some medications may influence dementia risk. We conducted a hypothesis-generating medication-wide association study to investigate systematically the association between all prescription medications and incident dementia. METHODS: We used a population-based cohort within the Secure Anonymised Information Linkage (SAIL) databank, comprising routinely-collected primary care, hospital admissions and …
The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control including hypoglycaemia. Long-acting insulin analogues were developed to reduce hypoglycaemia and improve adherence. Their considerably higher costs though have impacted their funding and use. Biosimilars …
No prominent works on this page.
The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control including hypoglycaemia. Long-acting insulin analogues were developed to reduce hypoglycaemia and improve adherence. Their considerably higher costs though have impacted their funding and use. Biosimilars …
Drug prescriptions and dementia incidence: A medication-wide association study of 17000 dementia cases among half a million participants
BACKGROUND: Previous studies have suggested that some medications may influence dementia risk. We conducted a hypothesis-generating medication-wide association study to investigate systematically the association between all prescription medications and incident dementia. METHODS: We used a population-based cohort within the Secure Anonymised Information Linkage (SAIL) databank, comprising routinely-collected primary care, hospital admissions and …
Environmental health (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Biosimilar (1 works) · Biosimilars and Bioanalytical Methods (1 works) · Business (1 works) · Cohort (1 works) · Cohort study (1 works) · Confidence interval (1 works) · Dementia (1 works)